Evidence map›Paper›PMID 40560495›Full record

ArticleAnnals of surgical oncology2025

Design and Validation of an Impaction-Nozzle Nebuliser for Enhanced Distribution Uniformity in Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC) Applications.

Yaroslaw Sautkin, Hans Schoenfelder, Marc André Reymond

Abstract readValidation Study
In one paragraph

Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yaroslaw SautkinNational Center for Pleura and Peritoneum, University of Tuebingen, Tuebingen, Germany. yaroslav_sautkin@gmx.de.
Hans SchoenfelderCapnoPharm GmbH, Tuebingen, Germany.
Marc André ReymondNational Center for Pleura and Peritoneum, University of Tuebingen, Tuebingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThis study introduces and validates the CapnoTip

methodsCapnoTip

resultsAerosol granulometry using distilled water measured 26.1 µm (confidence interval [CI] 13.6-59.6) for CapnoTip

conclusionsThe CapnoTip

Indexed as

Antineoplastic AgentsCisplatinDrug Delivery SystemsNebulizers and VaporizersPeritoneal NeoplasmsAerosolsAnimalsCattleEquipment DesignAerosolsAntineoplastic AgentsCisplatinAerosol chemotherapyCapnoPen®CapnoTip®CisplatinDoxorubicinPeritoneal carcinomatosisPeritoneal metastasisPIPAC

Identifiers

PMID40560495
PMCPMC12454613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.